Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005994 · ClinicalTrials.gov registry record · NA
Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy
A NA study of Unspecified Adult Solid Tumor, Protocol Specific and Nausea and Vomiting, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 4
- Study locations
NCT00005994: Completed NA study of Unspecified Adult Solid Tumor, Protocol Specific and Nausea and Vomiting, sponsored by University of Rochester.
NCT00005994 is a NA study of Unspecified Adult Solid Tumor, Protocol Specific and Nausea and Vomiting that has completed, run by University of Rochester. The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00005994, a NA study of Unspecified Adult Solid Tumor, Protocol Specific and Nausea and Vomiting, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 4
- Study locations
Study Summary
RATIONALE: Patient education may improve the effectiveness of ondansetron in preventing nausea and vomiting in patients receiving chemotherapy. PURPOSE: This randomized clinical trial is studying how well patient education works in preventing nausea and vomiting in cancer patients receiving chemotherapy.
Conditions Studied
Interventions
- DRUG ondansetron
Study Locations (4)
New York
- University of Rochester Cancer Center - Rochester
- CCOP - Syracuse Hematology-Oncology Associates of Central New York, P.C. - Syracuse
New Jersey
- Hackensack University Medical Center - Hackensack
North Carolina
- CCOP - Southeast Cancer Control Consortium - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Start Date | 2000-08 |
| Est. Completion | 2001-07 |
| Phase | NA |
What the finished NCT00005994 record still lists
NCT00005994 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 2 conditions, with Unspecified Adult Solid Tumor, Protocol Specific appearing as the primary indexed condition, and to 1 intervention - of which ondansetron is the first listed.
NCT00005994 reports a single indexed study location in New York, New Jersey, North Carolina.
Frequently Asked Questions
What is clinical trial NCT00005994 about?
NCT00005994 is a clinical study titled "Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy". RATIONALE: Patient education may improve the effectiveness of ondansetron in preventing nausea and vomiting in patients receiving chemotherapy. PURPOSE: This randomized clinical trial is studying how well patient education works in preventing nausea and vomiting in cancer patients receiving chemoth...
What is the current status of trial NCT00005994?
This trial is currently completed. It is a NA study. The study started on 2000-08. Estimated completion is 2001-07.
What conditions does trial NCT00005994 study?
This clinical trial studies the following conditions: Unspecified Adult Solid Tumor, Protocol Specific, Nausea and Vomiting.
What interventions are being tested in trial NCT00005994?
The interventions under investigation include: ondansetron (DRUG).
Who is sponsoring clinical trial NCT00005994?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00005994 being conducted?
This trial has 4 study locations across New Jersey, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Unspecified Adult Solid Tumor, Protocol Specific
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Assessment Tool for Older Patients With Cancer
ACTIVE NOT RECRUITING · NA
-
White Wine or Nutritional Supplement in Improving Appetite in Patients With Cancer
COMPLETED · NA
-
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
RECRUITING
-
Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors
RECRUITING
-
Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants
RECRUITING
-
Registry of Older Patients With Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia